← Leaderboards
Robert P Hebbel
University Of Minnesota Twin Cities
$14,706,560
Attributed
$15,746,656
Total exposure
13
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2005–12$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$33,084,823 · 14
By mechanism
P01$24,970,728 · 7
R01$3,476,354 · 4
T32$2,557,548 · 1
R21$1,447,142 · 1
R33$633,051 · 1
Top collaborators
- Clifford J. Steer4 shared
Most similar at University Of Minnesota Twin Cities
Same institution · by research overlap
- Clifford J. Steer$7,970,991
- Diane Jeanette Treat-Jacobson$3,567,444
Others in their field
Top investigators on “Sickle Cell Anemia”
- Russell E Ware · Duke University$48,435,687
- Michael Rutledge Debaun · Vanderbilt University Medical Center$38,268,866
- Martin H. Steinberg · Boston Medical Center$25,628,557
- Michael L. Terrin · Clinical Trials And Surveys Corporation$23,855,067
- Barbara L Kroner · Research Triangle Institute$21,141,016
- Garret A Fitzgerald · University Of Pennsylvania$20,602,198
Research focus
Sickle Cell AnemiaGene ExpressionVascular EndotheliumBlood VesselsProgramsPhenotypeStrokeAffectPeripheral BloodMonitorBone MarrowSickle CellBiologicalHematopoietic Stem CellsMediatingEndothelial CellsExhibitsSicklingTissue /Cell CultureHuman TissuePublic Health Medicine (Field)Quality ControlOrganMouse Model
Grant awards (57)
Non-viral gene therapy for sickle cell anemia$633,051
R33 · FY2012 · HL · contact PI
Vascular Pathobiology of Sickle Cell Disease$1,932,122
P01 · FY2011 · HL · contact PI
Non-viral gene therapy for sickle cell anemia$692,243
R21 · FY2011 · HL · contact PI
Transgenic Mouse$545,919
P01 · FY2011 · HL · contact PI
Endothelial Biology$382,210
P01 · FY2011 · HL · contact PI
Admininstration Core$86,042
P01 · FY2011 · HL · contact PI
Vascular Pathobiology of Sickle Cell Disease$1,932,122
P01 · FY2010 · HL · contact PI
Transgenic Mouse$545,919
P01 · FY2010 · HL · contact PI
Endothelial Biology$382,210
P01 · FY2010 · HL · contact PI
Non-viral gene therapy for sickle cell anemia$377,399
R21 · FY2010 · HL · contact PI
Admininstration Core$86,042
P01 · FY2010 · HL · contact PI
Vascular Pathobiology of Sickle Cell Disease$1,932,122
P01 · FY2009 · HL · contact PI
Transgenic Mouse$545,919
P01 · FY2009 · HL · contact PI
Endothelial Biology$382,210
P01 · FY2009 · HL · contact PI
Non-viral gene therapy for sickle cell anemia$377,500
R21 · FY2009 · HL · contact PI
Admininstration Core$86,042
P01 · FY2009 · HL · contact PI
Vascular Pathobiology of Sickle Cell Disease$1,893,478
P01 · FY2008 · HL · contact PI
GENETIC HETEROGENEITY IN ENDOTHELIAL GENE EXPRESSION$567,902
P01 · FY2008 · HL · contact PI
Transgenic Mouse$545,919
P01 · FY2008 · HL · contact PI
Endothelial Biology$382,210
P01 · FY2008 · HL · contact PI
Admininstration Core$86,042
P01 · FY2008 · HL · contact PI
Vascular Pathobiology of Sickle Cell Disease$1,944,497
P01 · FY2007 · HL · contact PI
Transgenic Mouse$545,919
P01 · FY2007 · HL · contact PI
GENETIC HETEROGENEITY IN ENDOTHELIAL GENE EXPRESSION$399,776
P01 · FY2007 · HL · contact PI
Hematology Research Training Program$397,161
T32 · FY2007 · HL · contact PI
Endothelial Biology$382,210
P01 · FY2007 · HL · contact PI
Admininstration Core$86,042
P01 · FY2007 · HL · contact PI
Hematology Research Training Program$396,423
T32 · FY2006 · HL · contact PI
GENETIC HETEROGENEITY IN ENDOTHELIAL GENE EXPRESSION$381,458
P01 · FY2006 · HL · contact PI
Vascular Pathobiology of Sickle Cell Disease$1,717,292
P01 · FY2005 · HL
GENETIC HETEROGENEITY IN ENDOTHELIAL GENE EXPRESSION$372,331
P01 · FY2005 · HL
BOEC in Biology$297,000
R01 · FY2005 · HL
Hematology Research Training Program$225,754
T32 · FY2005 · HL
Vascular Pathobiology of Sickle Cell Disease$1,553,012
P01 · FY2004 · HL
GENETIC HETEROGENEITY IN ENDOTHELIAL GENE EXPRESSION$538,473
P01 · FY2004 · HL
Hematology Research Training Program$316,029
T32 · FY2004 · HL
BOEC in Biology$297,000
R01 · FY2004 · HL
Vascular Pathobiology of Sickle Cell Disease$1,507,773
P01 · FY2003 · HL
Hematology Research Training Program$412,400
T32 · FY2003 · HL
BOEC in Biology$297,000
R01 · FY2003 · HL
Vascular Pathobiology of Sickle Cell Disease$1,463,976
P01 · FY2002 · HL
Hematology Research Training Program$398,857
T32 · FY2002 · HL
DEVELOPMENTAL HEMATO-ENDOTHELIAL BIOLOGY OF P1H12$396,250
R01 · FY2002 · DK
ERYTHROCYTE MEMBRANE ABNORMALITIES IN SICKLE DISEASE$312,087
R01 · FY2002 · HL
BOEC in Biology$297,000
R01 · FY2002 · HL
CORE--TRANSGENIC ANIMALS$150,883
P01 · FY2002 · HL
REPERFUSION INJURY$150,883
P01 · FY2002 · HL
Vascular Pathobiology of Sickle Cell Disease$1,461,773
P01 · FY2001 · HL
DEVELOPMENTAL HEMATO-ENDOTHELIAL BIOLOGY OF P1H12$384,710
R01 · FY2001 · DK
ERYTHROCYTE MEMBRANE ABNORMALITIES IN SICKLE DISEASE$304,707
R01 · FY2001 · HL
TRAINING IN HEMOGLOBIN &CELL MEMBRANE RESEARCH$211,795
T32 · FY2001 · HL
ENDOTHELIAL CELL OUTGROWTH FROM BLOOD$101,928
R01 · FY2001 · HL
DEVELOPMENTAL HEMATO-ENDOTHELIAL BIOLOGY OF P1H12$41,136
R01 · FY2001 · DK
DEVELOPMENTAL HEMATO-ENDOTHELIAL BIOLOGY OF P1H12$332,370
R01 · FY2000 · DK
ERYTHROCYTE MEMBRANE ABNORMALITIES IN SICKLE DISEASE$313,238
R01 · FY2000 · HL
TRAINING IN HEMOGLOBIN &CELL MEMBRANE RESEARCH$199,129
T32 · FY2000 · HL
ENDOTHELIAL CELL OUTGROWTH FROM BLOOD$101,928
R01 · FY2000 · HL